211 related articles for article (PubMed ID: 15094227)
1. Cortistatin production by HepG2 human hepatocellular carcinoma cell line and distribution of somatostatin receptors.
Notas G; Kolios G; Mastrodimou N; Kampa M; Vasilaki A; Xidakis C; Castanas E; Thermos K; Kouroumalis E
J Hepatol; 2004 May; 40(5):792-8. PubMed ID: 15094227
[TBL] [Abstract][Full Text] [Related]
2. RT-PCR and immunocytochemistry studies support the presence of somatostatin, cortistatin and somatostatin receptor subtypes in rat Kupffer cells.
Xidakis C; Mastrodimou N; Notas G; Renieri E; Kolios G; Kouroumalis E; Thermos K
Regul Pept; 2007 Oct; 143(1-3):76-82. PubMed ID: 17481746
[TBL] [Abstract][Full Text] [Related]
3. Octreotide inhibits proliferation and induces apoptosis of hepatocellular carcinoma cells.
Liu HL; Huo L; Wang L
Acta Pharmacol Sin; 2004 Oct; 25(10):1380-6. PubMed ID: 15456543
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of human dopamine D2 and somatostatin receptor subtype expression by glucocorticoids in vitro.
de Bruin C; Feelders RA; Waaijers AM; van Koetsveld PM; Sprij-Mooij DM; Lamberts SW; Hofland LJ
J Mol Endocrinol; 2009 Jan; 42(1):47-56. PubMed ID: 18852217
[TBL] [Abstract][Full Text] [Related]
5. Somatostatin enhances the chemosensitivity of GBC-SD cell line to doxorubicin through arresting the cell cycle to S phase rather than through the P53/Bax-depended apoptosis way in vitro.
Songgang L; Jiyu L; Gongwei ; Yingbin L; Yiyu Q; Zhiwei Q
Hepatogastroenterology; 2009; 56(94-95):1253-60. PubMed ID: 19950772
[TBL] [Abstract][Full Text] [Related]
6. [Inhibitory effect of blocking expression of human augmenter of liver regeneration (hALR) on proliferation of hepatocellular carcinoma cell line HepG2].
Tang L; Sun H; Zhang L; Guo H; Zhang L; Liu Q
Ai Zheng; 2006 Jun; 25(6):671-6. PubMed ID: 16764759
[TBL] [Abstract][Full Text] [Related]
7. Therapy of experimental hepatic cancers with cytotoxic peptide analogs targeted to receptors for luteinizing hormone-releasing hormone, somatostatin or bombesin.
Szepeshazi K; Schally AV; Treszl A; Seitz S; Halmos G
Anticancer Drugs; 2008 Apr; 19(4):349-58. PubMed ID: 18454045
[TBL] [Abstract][Full Text] [Related]
8. Expression of Somatostatin, cortistatin, and their receptors, as well as dopamine receptors, but not of neprilysin, are reduced in the temporal lobe of Alzheimer's disease patients.
Gahete MD; Rubio A; Durán-Prado M; Avila J; Luque RM; Castaño JP
J Alzheimers Dis; 2010; 20(2):465-75. PubMed ID: 20164562
[TBL] [Abstract][Full Text] [Related]
9. The inhibitory effect of opioids on HepG2 cells is mediated via interaction with somatostatin receptors.
Notas G; Kampa M; Nifli AP; Xidakis K; Papasava D; Thermos K; Kouroumalis E; Castanas E
Eur J Pharmacol; 2007 Jan; 555(1):1-7. PubMed ID: 17113072
[TBL] [Abstract][Full Text] [Related]
10. Truncated somatostatin receptors as new players in somatostatin-cortistatin pathophysiology.
Córdoba-Chacón J; Gahete MD; Durán-Prado M; Luque RM; Castaño JP
Ann N Y Acad Sci; 2011 Mar; 1220():6-15. PubMed ID: 21388399
[TBL] [Abstract][Full Text] [Related]
11. Role of the Fas/FasL pathway in combination therapy with interferon-alpha and fluorouracil against hepatocellular carcinoma in vitro.
Nakamura M; Nagano H; Sakon M; Yamamoto T; Ota H; Wada H; Damdinsuren B; Noda T; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Nakamori S; Dono K; Monden M
J Hepatol; 2007 Jan; 46(1):77-88. PubMed ID: 17045692
[TBL] [Abstract][Full Text] [Related]
12. Antineoplastic mechanism of Octreotide action in human hepatoma.
Chen X; Liu Z; Ai Z
Chin Med J (Engl); 2001 Nov; 114(11):1167-70. PubMed ID: 11729512
[TBL] [Abstract][Full Text] [Related]
13. [Effects of COX-2 gene silencing by shRNA on biological characteristics of human hepatocellular carcinoma cell line HepG2].
Xu KS; Wang HF; Qian W; Wang BH
Ai Zheng; 2007 Jan; 26(1):32-7. PubMed ID: 17222364
[TBL] [Abstract][Full Text] [Related]
14. [Effect of HBV X gene transfection on octreotide-inhibited growth of hepatocellular carcinoma cell line HepG2].
Xie Y; Tang CW; Wang CH
Ai Zheng; 2005 Aug; 24(8):965-9. PubMed ID: 16086874
[TBL] [Abstract][Full Text] [Related]
15. [Effect of brain-derived neurotrophic factor on in vitro metastasis of hepatocellular carcinoma cell line HepG2].
Xiao ZY; Wang YD; Chen XP
Ai Zheng; 2006 Mar; 25(3):287-91. PubMed ID: 16536980
[TBL] [Abstract][Full Text] [Related]
16. [The influence of downregulation of ezrin expression by RNA interference on the growth and metastasis of hepatocellular carcinoma: experiment in vitro].
Zhang Y; Hu MY; Chen BH; Wang ZJ; Zha XL; Liu KD
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(8):530-5. PubMed ID: 16681881
[TBL] [Abstract][Full Text] [Related]
17. [Inhibition of SMYD3 gene expression by RNA interference induces apoptosis in human hepatocellular carcinoma cell line HepG2].
Xu JY; Chen LB; Xu JY; Yang Z; Wei HY; Xu RH
Ai Zheng; 2006 May; 25(5):526-32. PubMed ID: 16687068
[TBL] [Abstract][Full Text] [Related]
18. [Induction of necrosis in the hepatocellular carcinoma HepG2 xenografts treated with SOM230].
Xie Y; Chen S; Wang CH; Tang CW
Zhonghua Gan Zang Bing Za Zhi; 2009 Oct; 17(10):759-64. PubMed ID: 19874692
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms and influence of octreotide-induced regulation of somatostatin receptor 2 on hepatocellular carcinoma.
Hua YP; Yin XY; Peng BG; Li SQ; Lai JM; Liang HZ; Liang LJ
Chemotherapy; 2009; 55(5):312-20. PubMed ID: 19590186
[TBL] [Abstract][Full Text] [Related]
20. Potent induction of apoptosis in human hepatoma cell lines by targeted cytotoxic somatostatin analogue AN-238.
Lasfer M; Vadrot N; Schally AV; Nagy A; Halmos G; Pessayre D; Feldmann G; Reyl-Desmars FJ
J Hepatol; 2005 Feb; 42(2):230-7. PubMed ID: 15664249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
